Evidence map›Paper›PMID 25701594›Full record

ArticlePhysiology & behavior2015

Metabotropic glutamate receptor-mediated signaling dampens the HPA axis response to restraint stress.

Nathan K Evanson, James P Herman

Abstract read
In one paragraph

Article in Physiology & behavior, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.1field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Infection byPathogens (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Nathan K EvansonCincinnati Children's Hospital Medical Center, Division of Pediatric Rehabilitation, United States. Electronic address: Nathan.evanson@cchmc.org.
James P HermanUniversity of Cincinnati, Department of Psychiatry and Behavioral Neuroscience, United States.
Cincinnati Children's Hospital Medical Center · USUniversity of Cincinnati · US

Funding

FUNCTIONAL ANATOMY OF LIMBIC NEUROENDOCRINE CIRCUITSR01MH049698 · NIMH · UNIVERSITY OF KENTUCKY · PI HERMAN, JAMES P · 1998 to 2018
$6.2M
PREDOCTORAL TRAINING PROGRAM IN THE NEUROSCIENCEST32NS007453 · NINDS · UNIVERSITY OF CINCINNATI · PI HERMAN, JAMES P · 1997 to 2025
$4.0M
Anatomical Plasticity and HPA Axis DysfunctionR01MH069725 · NIMH · UNIVERSITY OF CINCINNATI · PI HERMAN, JAMES P · 2005 to 2009
$1.9M
NIMH NIH HHS MH069725NIMH NIH HHS R01 MH069725NINDS NIH HHS NS007453NINDS NIH HHS T32 NS007453
6 · The paper itself

Abstract

Glutamate is an important neurotransmitter in the regulation of the neural portion of hypothalamus-pituitary-adrenal (HPA) axis activity, and signals through ionotropic and metabotropic receptors. In the current studies we investigated the role of hypothalamic paraventricular group I metabotropic glutamate receptors in the regulation of the HPA axis response to restraint stress in rats. Direct injection of the group I metabotropic glutamate receptor agonist 3,5-dihydroxyphenylglycine (DHPG) into the PVN prior to restraint leads to blunting of the HPA axis response in awake animals. Consistent with this result, infusion of the group I receptor antagonist hexyl-homoibotenic acid (HIBO) potentiates the HPA axis response to restraint. The excitatory effect of blocking paraventricular group I metabotropic glutamate signaling is blocked by co-administration of dexamethasone into the PVN. However, the inhibitory effect of DHPG is not affected by co-administration of the cannabinoid CB1 receptor antagonist AM-251 into the PVN. Together, these results suggest that paraventricular group I metabotropic glutamate receptor signaling acts to dampen HPA axis reactivity. This effect appears to be similar to the rapid inhibitory effect of glucocorticoids at the PVN, but is not mediated by endocannabinoid signaling.

Indexed as

Restraint, PhysicalAdrenocorticotropic HormoneAnalysis of VarianceAnimalsArea Under CurveCorticosteroneExcitatory Amino Acid AgentsHypothalamo-Hypophyseal SystemMalePituitary-Adrenal SystemRadioimmunoassayRatsReceptors, Metabotropic GlutamateTime FactorsAdrenocorticotropic HormoneCorticosteroneExcitatory Amino Acid AgentsReceptors, Metabotropic GlutamateGlucocorticoidsGlutamateHPA axisMetabotropicRatsStress

Identifiers

PMID25701594
PMCPMC4544613
OpenAlexW2051823618

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.